Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3079)
All Articles published online
|
Nov 15, 2004 (publication date) through Nov 9, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Meng H, Lu CD, Sun YL, Dai DJ, Lee SW, Tanigawa N. Expression level of wild-type survivin in gastric cancer is an independent predictor of survival. World J Gastroenterol 2004; 10(22): 3245-3250 [PMID: 15484293 DOI: 10.3748/wjg.v10.i22.3245] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i22/3245.htm |
| Number | Citing Articles |
| 1 |
Wan-Sik Lee, Sung-Bum Cho, Jong-Sun Rew, Jae-Hyuk Lee, Chang-Soo Park, Young-Eun Joo. Expression of Survivin in Gastric Carcinoma and its Relation to Tumor Cell Proliferation and Apoptosis. The Korean Journal of Pathology 2009; 43(4): 329 doi: 10.4132/KoreanJPathol.2009.43.4.329
|
| 2 |
Antonio Rosato, Michela Pivetta, Anna Parenti, Gaetano A. Iaderosa, Alessia Zoso, Gabriella Milan, Susanna Mandruzzato, Paola Del Bianco, Alberto Ruol, Giovanni Zaninotto, Paola Zanovello. Survivin in esophageal cancer: An accurate prognostic marker for squamous cell carcinoma but not adenocarcinoma. International Journal of Cancer 2006; 119(7): 1717 doi: 10.1002/ijc.21923
|
| 3 |
Takashi Suzuki. Research on Analysis of Final Diagnosis and Prognostic Factors, and Development of New Therapeutic Drugs for Malignant Tumors (Especially Malignant Pediatric Tumors). YAKUGAKU ZASSHI 2020; 140(2): 229 doi: 10.1248/yakushi.19-00178
|
| 4 |
Ishrat Rasool, Dil Afroze, Khursheed Alam Wani, Syed Basina Yasin, Adfar Yousuf, Showket Hussain, Shweta Dubey. Altered expression of survivin and its splice variants ∆Ex3 and 2B contributes to disease development in breast cancer. Meta Gene 2019; 19: 168 doi: 10.1016/j.mgene.2018.11.011
|
| 5 |
Elizabeth K. Balcer-Kubiczek, Michael C. Garofalo. Apoptosis in Carcinogenesis and Chemotherapy. 2009; : 157 doi: 10.1007/978-1-4020-9597-9_7
|
| 6 |
Yun-Ji Kim, Yi-Deun Jung, Tae-Oh Kim, Heui-Soo Kim. Alu-related transcript of TJP2 gene as a marker for colorectal cancer. Gene 2013; 524(2): 268 doi: 10.1016/j.gene.2013.04.006
|
| 7 |
Sepideh Hamzehlou, Majid Momeny, Zahra Zandi, Bahareh Kashani, Hassan Yousefi, Ahmad R. Dehpour, Javad Tavakkoly-Bazzaz, Seyed H. Ghaffari. Anti-tumor activity of neratinib, a pan-HER inhibitor, in gastric adenocarcinoma cells. European Journal of Pharmacology 2019; 863: 172705 doi: 10.1016/j.ejphar.2019.172705
|
| 8 |
Hung-Wen Tsai, Shu-Wen Cheng, Chou-Cheng Chen, I-Wen Chen, Chung-Liang Ho. A combined bioinformatics and experimental approach identifies RMI2 as a Wnt/β-catenin signaling target gene related to hepatocellular carcinoma. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-10655-2
|
| 9 |
Kimio Yonesaka, Kenji Tamura, Takayasu Kurata, Taroh Satoh, Masato Ikeda, Masahiro Fukuoka, Kazuhiko Nakagawa. Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycin. International Journal of Cancer 2006; 118(4): 812 doi: 10.1002/ijc.21350
|
| 10 |
W. Velando Rankin, C. J. Henry, S. E. Turnquist, J. R. Turk, M. E. Beissenherz, J. W. Tyler, E. B. Rucker, D. W. Knapp, C. O. Rodriguez, J. A. Green. Identification of survivin, an inhibitor of apoptosis, in canine urinary bladder transitional cell carcinoma*. Veterinary and Comparative Oncology 2008; 6(3): 141 doi: 10.1111/j.1476-5829.2007.00150.x
|
| 11 |
F Li. Role of survivin and its splice variants in tumorigenesis. British Journal of Cancer 2005; 92(2): 212 doi: 10.1038/sj.bjc.6602340
|
| 12 |
Salma Khan, Heather Ferguson Bennit, David Turay, Mia Perez, Saied Mirshahidi, Yuan Yuan, Nathan R Wall. Early diagnostic value of survivin and its alternative splice variants in breast cancer. BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-176
|
| 13 |
Ke-yan Cheng, Zhi-lian Wang, Qian-yun Gu, Min Hao, Andreas Krieg. Survivin Overexpression Is Associated with Aggressive Clinicopathological Features in Cervical Carcinoma: A Meta-Analysis. PLOS ONE 2016; 11(10): e0165117 doi: 10.1371/journal.pone.0165117
|
| 14 |
Masato Ikeda, Isamu Okamoto, Kenji Tamura, Taroh Satoh, Kimio Yonesaka, Masahiro Fukuoka, Kazuhiko Nakagawa. Down-regulation of survivin by ultraviolet C radiation is dependent on p53 and results in G2–M arrest in A549 cells. Cancer Letters 2007; 248(2): 292 doi: 10.1016/j.canlet.2006.08.005
|
| 15 |
Sam Kalungi, Henry Wabinga, Leif Bostad. Expression of apoptosis associated proteins Survivin, Livin and Thrombospondin‐1 in Burkitt lymphoma. APMIS 2013; 121(3): 239 doi: 10.1111/j.1600-0463.2012.02962.x
|
| 16 |
Quan-Xing Ge, Yu-Yuan Li, Yu-Qiang Nie, Wen-Ge Zuo, Yan-Lei Du. Expression of survivin and its four splice variants in colorectal cancer and its clinical significances. Medical Oncology 2013; 30(2) doi: 10.1007/s12032-013-0535-6
|
| 17 |
Rami G. Azrak, Cheryl L. Frank, Xiang Ling, Harry K. Slocum, Fengzhi Li, Barbara A. Foster, Youcef M. Rustum. The mechanism of methylselenocysteine and docetaxel synergistic activity in prostate cancer cells. Molecular Cancer Therapeutics 2006; 5(10): 2540 doi: 10.1158/1535-7163.MCT-05-0546
|
| 18 |
Yun-Ji Kim, Jae-Won Huh, Dae-Soo Kim, Min-In Bae, Ja-Rang Lee, Hong-Seok Ha, Kung Ahn, Tae-Oh Kim, Geun-Am Song, Heui-Soo Kim. Molecular characterization of the DYX1C1 gene and its application as a cancer biomarker. Journal of Cancer Research and Clinical Oncology 2009; 135(2): 265 doi: 10.1007/s00432-008-0445-8
|
| 19 |
Muhammad Wasif Saif, Antonis Zalonis, Kostas Syrigos. The clinical significance of autoantibodies in gastrointestinal malignancies: an overview. Expert Opinion on Biological Therapy 2007; 7(4): 493 doi: 10.1517/14712598.7.4.493
|
| 20 |
Eiji Osaka, Takashi Suzuki, Shunzo Osaka, Yukihiro Yoshida, Hideyuki Sugita, Satoru Asami, Keiichi Tabata, Masahiko Sugitani, Norimichi Nemoto, Junnosuke Ryu. Survivin expression levels as independent predictors of survival for osteosarcoma patients. Journal of Orthopaedic Research 2007; 25(1): 116 doi: 10.1002/jor.20291
|